Complete Response to Temozolomide in Metastatic Melanoma After Failure of 5 Lines of Treatment

被引：4
|
作者：
Magge, Tara [1 ]
Shaikh, Hira [2 ]
Chaudhary, Rekha [2 ]
机构：
[1] Univ Cincinnati, Dept Internal Med, Cincinnati, OH 45221 USA
[2] Univ Cincinnati, Dept Hematol & Oncol, Cincinnati, OH USA
来源：
AMERICAN JOURNAL OF THERAPEUTICS | 2022年 / 29卷 / 06期
关键词：
PHASE-III; CHEMOTHERAPY; SURVIVAL; INHIBITORS; NIVOLUMAB; RATES;
D O I：
10.1097/MJT.0000000000001186
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：E767 / E769
页数：3
相关论文
共 50 条
  • [41] Length of treatment after partial or complete remission in immunotherapy for metastatic melanoma: An EUMelaReg real world study
    Asher, Nethanel
    Mohr, Peter
    Ellebaek, Eva
    Bender, Marc
    Mangana, Joanna
    Kandolf, Lidija
    Gavrilova, Iva
    Ascierto, Paolo Antonio
    Gogas, Helen
    Rutkowski, Piotr
    Schadendorf, Dirk
    Bastholt, Lars
    Weichenthal, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [42] DURATION OF REMISSION FOLLOWING COMPLETE RESPONSE (CR) TO CHEMOTHERAPY FOR METASTATIC MELANOMA
    HILL, GJ
    KREMENTZ, ET
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 188 - 188
  • [43] BRAFi/MEKi in patients with metastatic melanoma: predictive factors of complete response
    Ribero, Simone
    Malavenda, Ottavia
    Fava, Paolo
    Astrua, Chiara
    Marra, Elena
    Osella-Abate, Simona
    Sanlorenzo, Martina
    Caliendo, Virginia
    Fierro, Maria Teresa
    Quaglino, Pietro
    FUTURE ONCOLOGY, 2019, 15 (02) : 133 - 139
  • [44] Complete regression of metastatic malignant melanoma endoscopically after nivolumab administration
    Ryu, Dae Gon
    Choi, Cheol Woong
    Kim, Su Jin
    Kang, Dae Hwan
    Park, Su Bum
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2021, 36 (06): : 1532 - 1533
  • [45] A response to the ipilimumab treatment of a patient with a diagnosis of metastatic melanoma
    Pekala, Anika
    Ulanska, Malgorzata
    Blasinska-Morawiec, Maria
    ONCOLOGY IN CLINICAL PRACTICE, 2015, 11 : H1 - H6
  • [46] Metastatic Melanoma Vitiligo as a Marker for good Treatment Response?
    Strobel, Kathrin
    AKTUELLE DERMATOLOGIE, 2016, 42 (03) : 74 - 74
  • [47] BMI and response to systemic treatment in melanoma metastatic patients
    Marsan, F.
    Nguyen, J. M.
    Varey, E.
    Fronteau, C.
    Khammari, A.
    Dreno, B.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (01) : E51 - E53
  • [48] Metastatic pancreatic cancer with complete response to FOLFIRINOX treatment
    Shelemey, Paige T.
    Amaro, Carla P.
    Ng, Danny
    Falck, Vincent
    Tam, Vincent C.
    BMJ CASE REPORTS, 2021, 14 (05)
  • [49] Complete Response of Metastatic Malignant Hidradenocarcinoma to Capecitabine Treatment
    Lerner, Adam
    Beckford, Angela
    Ugent, Steve
    Goldberg, Lynne
    Jalisi, Scharukh
    Demierre, Marie-France
    ARCHIVES OF DERMATOLOGY, 2011, 147 (08) : 998 - 999
  • [50] CNS Demyelination after Treatment with Nivolumab for Metastatic Melanoma
    Popinhak, B.
    Fernandes, G.
    Andrade, H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 1175 - 1175
12345